⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL419051 | 0.72 | — | — | |
| Sulfamide SCHEMBL5880 | 0.72 | — | — | |
| SCHEMBL5115519 | 0.67 | — | — | |
| Sulfamide SCHEMBL1000467 | 0.67 | — | — | |
| Sulfamide SCHEMBL10866317 | 0.67 | — | — | |
| Sulfamide SCHEMBL3409127 | 0.67 | — | — | |
| Sulfamide SCHEMBL5667325 | 0.67 | — | — | |
| SCHEMBL6064216 | 0.67 | — | — | |
| Sulfamide SCHEMBL17495597 | 0.67 | — | — | |
| Sulfamide SCHEMBL3827754 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0823913-B1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2006-01-11 | — | — | EP | claimed |
| EP-0951484-A4 | COLON CANCER KH-1 AND N3 ANTIGENS | SLOAN KETTERING INST CANCER (US) | 2003-03-12 | — | — | EP | claimed |
| US-20020006900-A1 | Antitumor agents; anticarcinogenic agents | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-01-17 | — | — | US | claimed |
| EP-0951484-A2 | COLON CANCER KH-1 AND N3 ANTIGENS | Sloan-Kettering Institute For Cancer Research (US) | 1999-10-27 | — | — | EP | claimed |
| EP-0823913-A4 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 1998-11-04 | — | — | EP | claimed |
| WO-1998030190-A2 | COLON CANCER KH-1 AND N3 ANTIGENS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0823913-A1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1998-02-18 | — | — | EP | claimed |
| US-5708163-A | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof | SLOAN-KETTERING INSTITUTE OF CANCER RESEARCH (US) | 1998-01-13 | — | — | US | claimed |
| WO-1996034005-A1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-10-31 | — | — | WO | claimed |
| US-20250051364-A1 | KRAS G12D Proteolysis Targeting Chimeras | PAQ Therapeutics Inc. (US) | 2025-02-13 | — | — | US | disclosed |
| US-20210325398-A1 | TARGETED SIALIC ACID LABELING COMPOUNDS, METHODS, AND USES THEREOF | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT | 2021-10-21 | — | — | US | disclosed |
| WO-2017147410-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2017-08-31 | — | — | WO | disclosed |
| US-9493580-B2 | Multivalent glycopeptide constructs and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2675803-A1 | MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS | Elanco Animal Health Ireland Limited (IE) | 2013-12-25 | — | — | EP | disclosed |
| US-5543505-A | TREATMENT OF GASTROINTESTINAL DISORDERS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-08-06 | — | — | US | disclosed |
| EP-0495594-B1 | Sulphonamide derivatives | ZENECA LTD (GB) | 1996-03-20 | — | — | EP | disclosed |
| WO-1995025113-A1 | SYNTHETIC COMPOUNDS WHICH BIND TO H. PYLORI, AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-09-21 | — | — | WO | disclosed |
| US-5258399-A | 5-lipoxygenase inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-11-02 | — | — | US | disclosed |
| US-5236948-A | Lipoxygenase inhibitor | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-08-17 | — | — | US | disclosed |
| EP-0495594-A1 | Sulphonamide derivatives | ZENECA LIMITED (GB) | 1992-07-22 | — | — | EP | disclosed |